TVRD
Tvardi Therapeutics, Inc.
NASDAQ: TVRD · HEALTHCARE · BIOTECHNOLOGY
$3.15
+2.94% today
Updated 2026-04-30
Market cap
$30.02M
P/E ratio
—
P/S ratio
559.61x
EPS (TTM)
$-3.26
Dividend yield
—
52W range
$3 – $44
Volume
0.0M
Tvardi Therapeutics, Inc. (TVRD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-237.80%
ROA
-49.70%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $135.08M | $8.41M | — | 3.99% | 6.23% |
| 2021 | $23.03M | $-88.44M | 93.25% | -386.85% | -384.06% |
| 2022 | $41.87M | $-85.47M | 82.05% | -209.08% | -204.16% |
| 2023 | $20.97M | $-118.51M | 69.32% | -579.43% | -565.21% |
| 2024 | $7.14M | $-70.87M | 88.62% | -781.57% | -992.95% |
| 2025 | $0.00 | $-18.21M | — | — | — |